Document is current
Any future updates will be listed below
-
Authors
Thomsen, Magda Teresa
Høgh, Julie
Knudsen, Andreas Dehlbæk
Jensen, Anne Marie Reimer
Gelpi, Marco
Villadsen, Gerda E.
Abazi, Rozeta
Holland-Fischer, Peter
Køber, Lars
Clemmesen, Otto
Krohn, Paul Suno
Hillingsø, Jens
Vilsbøll, Tina
Biering-Sørensen, Tor
Kofoed, Klaus Fuglsang
Nordestgaard, Børge Grønne
Rasmussen, Allan
Nielsen, Susanne Dam https://orcid.org/0000-0001-6391-7455
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04777032 at ClinicalTrials.govDocuments that mention this clinical trial
The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study
https://doi.org/10.1186/s12876-021-01733-5
-
Funding
Funding for this research was provided by:
Rigshospitalet
Svend Andersen Fonden
Kirsten og Freddy Johansens Fond
- License Information
-
More Information
Article History
Received: 3 March 2021
Accepted: 23 March 2021
First Online: 1 April 2021
Declarations
:
: All participants provide oral and written informed consent before study inclusion. The DACOLT study (H-20052199), CGPS (H-KF-01-144/01) and CCHS (HEH-2015-045) have obtained approval from the Ethics Committee of the Capital Region, Denmark.
: Not applicable.
: M.T.T. reports a grant from the Rigshospitalets Research Council. J.H. reports grant from Novo Nordisk Foundation and Rigshospitalets Research Council. A.D.K. reports a grant from the Danish Heart Foundation not in relation to this work. T.V. has served on scientific advisory panels, been part of speaker’s bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gilead, MSD/Merck, Mundipharma, Novo Nordisk, Sanofi and Sun Pharmaceuticals. S.D.N. has received unrestricted research grants from Novo Nordisk Foundation, Svend Andersen Foundation, Kirsten and Freddy Johansen Foundation, Rigshospitalet Research Council. All other authors report no conflicts of interest.
